Barry D Quart
CIK 1384243 · Chief Executive Officer · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$869.6K
Companies
4
Total Filings
80
Lifetime Open-Market Net
-$15.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KNSA | Director | 15,345 | $51.89 | $796.3K | -$3.87M | 16 | 2026-06-02 |
| HRTX | Chief Executive Officer | 183,208 | $0.40 | $73.3K | -$7.45M | 29 | 2023-01-20 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | Director | — | — | — | $0 | 5 | 2015-06-23 |
| Ardea Biosciences, Inc./DE (RDEA) Delisted | President and CEO | 2,500 | — | — | -$4.05M | 20 | 2012-06-20 |
Recent Filings · Page 5 of 8
80 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-10-15 | HRTX | Exer (M) | +10,000 | $72.0K | EDGAR |
| 2015-09-30 | HRTX | Exer (M) | +14,306 | $103.0K | EDGAR |
| 2015-08-19 | HRTX | Mixed | +12,881 | $93.9K | EDGAR |
| 2015-06-23 | SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | Disp (D) | — | $0 | EDGAR |
| 2015-03-04 | HRTX | Sell (S) | −10,000 | -$130.7K | EDGAR |
| 2014-12-15 | HRTX | Mixed | −8,987 | $14.6K | EDGAR |
| 2014-01-07 | — | Grant (A) | — | $0 | |
| 2013-11-21 | — | Buy (P) | +1,000,000 | $400.0K | |
| 2013-06-10 | SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-05-03 | — | Grant (A) | — | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.